Farmak   Report issue

For profit Phase 1 Phase 3
Founded: Kyiv Ukraine (1925)
Status: No NME R&D (1925)

Organization Overview

First Clinical Trial
2009
NCT04682444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Joint Stock Company "Farmak"